CAROZZI, VALENTINA ALDA
 Distribuzione geografica
Continente #
NA - Nord America 9.620
EU - Europa 5.121
AS - Asia 2.050
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 21
SA - Sud America 15
AF - Africa 8
Totale 16.858
Nazione #
US - Stati Uniti d'America 9.413
CN - Cina 1.306
DE - Germania 1.027
IT - Italia 922
SE - Svezia 886
IE - Irlanda 817
UA - Ucraina 586
GB - Regno Unito 294
HK - Hong Kong 293
CA - Canada 204
VN - Vietnam 174
FI - Finlandia 138
AT - Austria 109
RU - Federazione Russa 106
FR - Francia 72
IN - India 66
DK - Danimarca 64
JP - Giappone 54
TR - Turchia 46
KR - Corea 32
BE - Belgio 29
NL - Olanda 29
SG - Singapore 25
MY - Malesia 22
EU - Europa 19
IR - Iran 16
NZ - Nuova Zelanda 13
BR - Brasile 11
AU - Australia 10
PL - Polonia 9
EG - Egitto 6
ES - Italia 5
PH - Filippine 5
RS - Serbia 5
TW - Taiwan 5
HR - Croazia 4
HU - Ungheria 4
CH - Svizzera 3
CL - Cile 3
MX - Messico 3
NO - Norvegia 3
RO - Romania 3
A1 - Anonimo 2
AE - Emirati Arabi Uniti 2
LB - Libano 2
SC - Seychelles 2
AL - Albania 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
EE - Estonia 1
IL - Israele 1
IQ - Iraq 1
MD - Moldavia 1
PT - Portogallo 1
VE - Venezuela 1
Totale 16.858
Città #
Ann Arbor 2.213
Woodbridge 900
Dublin 791
Chandler 741
Houston 650
Jacksonville 618
Frankfurt am Main 604
Fairfield 534
Dearborn 505
Wilmington 485
Ashburn 369
Milan 367
Hangzhou 332
New York 319
Princeton 304
Hong Kong 277
Seattle 219
Nanjing 199
Cambridge 165
Shanghai 108
Vienna 108
Lachine 102
Beijing 101
Altamura 92
Dong Ket 89
Lawrence 82
Guangzhou 73
Nanchang 72
Boardman 58
Shenyang 58
Andover 51
Toronto 44
Grafing 37
Jiaxing 35
Ottawa 34
Fremont 33
Changsha 32
San Diego 32
Hebei 31
Jinan 31
Carate Brianza 30
Tianjin 30
Helsinki 29
Falls Church 28
Nürnberg 28
Brussels 27
Kunming 24
Zhengzhou 24
London 23
Mountain View 22
Los Angeles 21
Ningbo 20
Pune 20
Shangdi 20
Codroipo 17
Tokyo 17
Bergamo 16
Norwalk 16
Leawood 14
Phoenix 14
Rome 14
Taizhou 14
Edmonton 13
Hefei 13
Pasir Mas 12
Shinjuku 12
Huizen 11
Kiev 11
Lissone 11
San Mateo 11
Paris 10
Sesto San Giovanni 10
Washington 10
Sacramento 9
Fuzhou 8
Auburn Hills 7
Bologna 7
Haikou 7
Philadelphia 7
Redmond 7
Ankara 6
Detroit 6
Elmhurst 6
Frederick 6
Monza 6
Piemonte 6
Suwon 6
University Park 6
Cabuyao 5
Changchun 5
Clarks Summit 5
Daejeon 5
Fasano 5
Laurel 5
Mainz 5
Menlo Park 5
Merate 5
Orange 5
Paderno Dugnano 5
Saint Louis 5
Totale 12.647
Nome #
Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice 403
Age-related changes in the function and structure of the peripheral sensory pathway in mice 286
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 276
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 273
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 266
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 257
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 253
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 222
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 221
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 220
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 207
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 201
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 190
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 185
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 170
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 169
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 169
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 166
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 164
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 164
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 157
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 157
Blood molecular biomarkers for chemotherapy-induced peripheral neuropathy: From preclinical models to clinical practice 156
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 152
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 151
Expression, distribution and glutamate uptake activity of high affinity-excitatory aminoacid transporters in in vitro cultures of embryonic rat dorsal root ganglia 151
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 150
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 150
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 146
Lipoplatin tm: a less neurotoxic formulation of cisplatin 144
Platinum-taxane combination chemotherapy: General and peripheral neurotoxicity of their combined administration in the rat 142
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 142
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 140
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 139
Focus on the role of Glutamate in the pathology of the peripheral nervous system 138
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 134
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 134
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 134
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 134
Lack of sterol regulatory element binding factor-1c imposes glial fatty acid utilization leading to peripheral neuropathy 133
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 131
The Role of Oxidative Stress and Anti-Oxidant Treatment in Platinum-Induced Peripheral Neurotoxicity 131
Docetaxel-induced peripheral neuropathy: Protective effects of dihydroprogesterone and progesterone in an experimental model 131
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 131
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 130
Pathogenesis of platinum-induced peripheral neurotoxicity: Insights from preclinical studies 130
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 129
Transplanted pancreatic islets survive and reverse type I diabetic neuropathy 126
Valproate protective effects on cisplatin-induced peripheral neuropathy: An in vitro and in vivo study 125
Regression of diabetic complications by islet transplantation in the rat 124
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 124
Long-term recovery from chemotherapy-induced neuropathy following paclitaxel, ixabepilone, eribulin and vinorelbine in mice 123
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 122
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 121
The role of glutamate in diabetic and in chemotherapy induced peripheral neuropathies and its regulation by glutamate carboxypeptidase II. 121
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 119
Multimodal experimental approach to the study of human neurological diseases 118
ERIBULIN, PACLITAXEL, IXABEPILONE AND VINORELBINE-INDUCED PERIPHERAL NEUROPATHY IN MICE: INSIGHTS IN LONG-TERM RECOVERY 118
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 116
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 115
Comparison of neuropathy-inducing effects of eribulin mesylate, paclitaxel, and ixabepilone in mice 114
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 114
MSCs effect on Dark Agouti rats affected by chronic EAE 113
Ethoxyquin provides neuroprotection against cisplatin-induced neurotoxicity 113
Imunohystochemical characterization of the distribution of glutamate receptors, “high affinity” membrane bound glutamate transporters and of Glutamate Carboxipeptidase II (GCPII) in in vitro cultures of embryonic dorsal root ganglia. 112
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 112
Bortezomib treatment produces nocifensive behavior and changes in the expression of TRPV1, CGRP, and substance P in the rat DRG, spinal cord, and sciatic nerve 111
Oxaliplatin Neurotoxicity is related to SLC4A1 Expression in BALB/c Mice Dorsal Root Ganglia 111
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 110
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 110
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 109
Neuroprotective effects of a ligand of translocator protein-18 kDa (Ro5-4864) in experimental diabetic neuropathy 107
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 107
Oxaliplatin induces pH acidification in dorsal root ganglia neurons 107
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 106
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 106
Co-trasplantation of Pancreatic Islets with Mesenchymal Stem Cells promotes the functional recovery of diabetic neuropathy in vivo 106
The severity of oxaliplatin neurotoxicity is related to differential expression of a solute transporter in mice 105
Characterization of Glutamate Transporters in Peripheral Nervous System. 104
Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms? 104
Organic cation transporters and cisplatin-induced peripheral neurotoxicity in dorsal root ganglia neurons 103
Effect of proteasome inhibition on the central and peripheral nervous system 103
Expression, distribution and glutamate uptake activity of excitatory aminoacid transporters in in vitro cultures of embryonic rat dorsal root ganglia 103
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 103
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 102
Correlation between organic cation transporter expression in rat dorsal root ganglia neurons and cisplatin-induced peripheral neurotoxicity 102
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 101
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 101
electrophysiological, behavioural and morphological characterization of oxaliplatin-induced painful peripheral neuropathy in mice 101
Glutamate Carboxypeptidase II inhibition in several rat models of chemotherapy-induced peripheral neurotoxicity 101
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 101
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 101
Glutamate carboxypeptidase inhibition reduces the severity of chemotherapy-induced peripheral neurotoxicity in rat 97
Glutamate Carboxypeptidase II (GCPII, NAALADASE) inhibition protects against Cisplatin-induced peripheral neurotoxicity in a rat model. 97
Functional recovery with syngeneically transplanted microcapsulated pancreatic islets in streptozotocin-induced diabetic rats. 94
EXPRESSION OF TRPV1 AND CGRP IN SPINAL PRIMARY AFFERENT NEURONS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY TREATED WITH ANALGESICS 93
Calcium-related neurotoxicity of oxaliplatin: Understanding the mechanisms to drive therapy 93
Neutrophil contribution and immunoglobulin effect in Dark Agouti Experimental Autoimmune Encephalomyelitis. 90
Aging Action on Peripheral Nervous System in C57bl/6 Mice: a Morphological and Morphometric Study 90
Oxaliplatin-Induced Peripheral Neurotoxicity: a Role for Genomics? 89
Totale 13.977
Categoria #
all - tutte 49.607
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.607


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019570 0 0 0 0 0 0 0 0 0 0 228 342
2019/20203.249 415 206 221 182 301 389 525 217 284 252 217 40
2020/20212.636 139 113 297 295 208 184 278 204 242 222 162 292
2021/20221.700 102 165 121 158 144 195 68 91 70 127 113 346
2022/20233.212 383 842 338 278 213 518 56 164 280 34 65 41
2023/20242.222 97 77 104 115 326 670 465 128 172 67 1 0
Totale 17.900